These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33826296)

  • 1. A Screen of Natural Product Extracts Identifies Moenomycin as a Potent Antigonococcal Agent.
    Yarlagadda V; Rao VN; Kaur M; Guitor AK; Wright GD
    ACS Infect Dis; 2021 Jun; 7(6):1569-1577. PubMed ID: 33826296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activity of synthetic analogues based on the disaccharide structure of moenomycin, an inhibitor of bacterial transglycosylase.
    Baizman ER; Branstrom AA; Longley CB; Allanson N; Sofia MJ; Gange D; Goldman RC
    Microbiology (Reading); 2000 Dec; 146 Pt 12():3129-3140. PubMed ID: 11101671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular biology of moenomycins: towards novel antibiotics based on inhibition of bacterial peptidoglycan glycosyltransferases.
    Ostash B; Doud E; Fedorenko V
    Biol Chem; 2010 May; 391(5):499-504. PubMed ID: 20302515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moenomycin is broadly active against multidrug-resistant Neisseria gonorrhoeae and clears an infection from a murine vaginal tract infection model.
    Yang F; Gao S; Yan J; Lin X; van der Veen S
    J Antimicrob Chemother; 2022 Aug; 77(9):2461-2469. PubMed ID: 35762496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of moenomycin on Escherichia coli.
    van Heijenoort Y; Leduc M; Singer H; van Heijenoort J
    J Gen Microbiol; 1987 Mar; 133(3):667-74. PubMed ID: 3309167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
    Tseng YY; Liou JM; Hsu TL; Cheng WC; Wu MS; Wong CH
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2412-4. PubMed ID: 24775303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete characterization of the seventeen step moenomycin biosynthetic pathway.
    Ostash B; Doud EH; Lin C; Ostash I; Perlstein DL; Fuse S; Wolpert M; Kahne D; Walker S
    Biochemistry; 2009 Sep; 48(37):8830-41. PubMed ID: 19640006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuning the moenomycin pharmacophore to enable discovery of bacterial cell wall synthesis inhibitors.
    Gampe CM; Tsukamoto H; Doud EH; Walker S; Kahne D
    J Am Chem Soc; 2013 Mar; 135(10):3776-9. PubMed ID: 23448584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive Optimization Boosted the Production of Moenomycin A in the Microbial Chassis
    Li X; Hu X; Sheng Y; Wang H; Tao M; Ou Y; Deng Z; Bai L; Kang Q
    ACS Synth Biol; 2021 Sep; 10(9):2210-2221. PubMed ID: 34470207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic factors that influence moenomycin production in streptomycetes.
    Makitrynskyy R; Rebets Y; Ostash B; Zaburannyi N; Rabyk M; Walker S; Fedorenko V
    J Ind Microbiol Biotechnol; 2010 Jun; 37(6):559-66. PubMed ID: 20204454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and structural analysis of a key region of the cell wall inhibitor moenomycin.
    Fuse S; Tsukamoto H; Yuan Y; Wang TS; Zhang Y; Bolla M; Walker S; Sliz P; Kahne D
    ACS Chem Biol; 2010 Jul; 5(7):701-11. PubMed ID: 20496948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MoeH5: a natural glycorandomizer from the moenomycin biosynthetic pathway.
    Ostash B; Campbell J; Luzhetskyy A; Walker S
    Mol Microbiol; 2013 Dec; 90(6):1324-38. PubMed ID: 24164498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aptamers that bind to the antibiotic moenomycin A.
    Schürer H; Stembera K; Knoll D; Mayer G; Blind M; Förster HH; Famulok M; Welzel P; Hahn U
    Bioorg Med Chem; 2001 Oct; 9(10):2557-63. PubMed ID: 11557343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance-Guided Discovery of Elfamycin Antibiotic Producers with Antigonococcal Activity.
    Yarlagadda V; Medina R; Johnson TA; Koteva KP; Cox G; Thaker MN; Wright GD
    ACS Infect Dis; 2020 Dec; 6(12):3163-3173. PubMed ID: 33164482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing Fluorescent Moenomycin A Antibiotics for Bacterial Cell Wall Imaging Studies.
    Hsieh PY; Meng FC; Guo CW; Hu KH; Shih YL; Cheng WC
    Chembiochem; 2021 Dec; 22(24):3462-3468. PubMed ID: 34606179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A surface plasmon resonance analysis of the interaction between the antibiotic moenomycin A and penicillin-binding protein 1b.
    Stembera K; Vogel S; Buchynskyy A; Ayala JA; Welzel P
    Chembiochem; 2002 Jun; 3(6):559-65. PubMed ID: 12325012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The total synthesis of moenomycin A.
    Taylor JG; Li X; Oberthür M; Zhu W; Kahne DE
    J Am Chem Soc; 2006 Nov; 128(47):15084-5. PubMed ID: 17117848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers that recognize the lipid moiety of the antibiotic moenomycin A.
    Betat H; Vogel S; Struhalla M; Förster HH; Famulok M; Welzel P; Hahn U
    Biol Chem; 2003; 384(10-11):1497-500. PubMed ID: 14669992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and analysis of moenomycin and its biosynthetic intermediates from Streptomyces ghanaensis (ATCC 14672) wildtype and selected mutants.
    Subramaniam-Niehaus B; Schneider T; Metzger JW; Wohlleben W
    Z Naturforsch C J Biosci; 1997; 52(3-4):217-26. PubMed ID: 9167274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation and reconstruction of moenomycin A and derivatives: dissecting the function of the isoprenoid chain.
    Adachi M; Zhang Y; Leimkuhler C; Sun B; LaTour JV; Kahne DE
    J Am Chem Soc; 2006 Nov; 128(43):14012-3. PubMed ID: 17061868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.